LeeNY,LeeCC,HuangWH,TsuiKC,HsuehPR,KoWC, 2013.Cefepime therapy for monomicrobial bacteraemia caused by cefepime-susceptible extended spectrum beta lactamase producing Enterobacteriaceae: MIC matters,Clin Infect Dis 56 488 -95
TammaPD,HanJH,RockC,HarrisAD,LantenbachE,HsuAJ, 2015.Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended spectrum -lactamase bacteraemia,Clin Infect Dis 60 1319 -25
PatelJB,CockerillFR,EliopoulosGM,JenkinsSG,LewisII JS,LimbagoB, 2016.M100S performance standards for antimicrobial susceptibility testing,Wayne PA: Clinical Laboratory Standards Institute 36 118 -21
AliAM,RafiS,QureshiAH, 2004.Frequency of extended spectrum beta lactamase producing gram-negative bacilli among clinical isolates at clinical laboratories of Army Medical College, Rawalpindi,J Ayub Med Coll Abbott bad 16 35 -7
GiriyapurRS,NandihalNW,KrishnaBVS,PatelAB,ChandrasekharMR, 2011.Comparison of disk diffusion methods for detection of extended spectrum beta lactamase producing Enterobacteriaceae,J Lab Physicians 3 33 -6
M'ZaliFH,ChanawongA,KerrKG,BirkenheadD,HawkeyePM, 2000.Detection of extended spectrum -lactamases in members of the family Enterobacteriaceae: comparison of the MAST DD test, the double disk and the Etest ESBL,J Antimicrob Chemother 45 881 -5
ThadenJT,FowlerVG,SextonDJ,AndersonDJ, 2016.Increasing incidence of extended spectrum -lactamase producing Escherichia coli in community hospitals throughout the Southeast United States,Infect Control Hosp Epidemiol 37 49 -54